Canlyniadau 1–20 o 281 ar gyfer speaker:Lord Kakkar

National Immunisation Programme - Question (23 Mai 2024)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my registered interests. Research, development and production of vaccines will increasingly represent an important part of our national security strategy. Is the Minister content that there is sufficient investment in those three elements to ensure that we can secure our biosecurity in the future?

Inflammatory Bowel Disease - Question (20 Mai 2024)

Lord Kakkar: My Lords, I draw your Lordships’ attention to my registered interests. To achieve the best outcomes for complex conditions such as inflammatory bowel disease, there is a requirement to ensure that patients are managed by properly skilled multidisciplinary teams. Is the Minister content that, with all the workforce pressures that exist, we are investing sufficiently to develop those teams...

Whooping Cough - Question (16 Mai 2024)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my interests in the register. To pick up the point of my noble friend Lord Patel, there is a difference in the trajectory with regard to the outcome of disease between the United Kingdom and other European countries. Might that be a manifestation of the fact that there have been changes in the way we address public health measures in our country?...

NHS: Long-term Sustainability - Motion to Take Note (18 Ebr 2024)

Lord Kakkar: My Lords, it is a great pleasure to follow the noble Lord, Lord Bethell, and to congratulate my noble friend Lord Patel on the thoughtful way in which he introduced this important debate. I declare my interests in the register, in particular as chairman of the King’s Fund and as chairman of King’s Health Partners. My noble friend alluded to the report of your Lordships’ ad hoc...

Stroke Treatment - Question (27 Maw 2024)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my registered interests. The Minister mentioned the importance of prevention, which of course is not only primary but secondary prevention. In that regard, for both patients with atrial fibrillation at risk of a stroke and those who have had a stroke, it is vitally important that appropriate therapies, innovations in therapeutic intervention, and...

Cancer: Staffing - Question (14 Maw 2024)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my registered interests. The Minister rightly identified an improvement in survival rates for those between their late 30s and 69 over the last 30 years. He also accepted the fact that those delivering cancer services are under a huge amount of pressure to ensure timely provision of that care. It is also essential to achieving long-term improvement...

Industrial Strategy - Motion to Take Note ( 1 Chw 2024)

Lord Kakkar: My Lords, I join other noble Lords in thanking the noble Lord, Lord Watson, for having secured this debate and in welcoming the opportunity to listen to the maiden speech of the noble Lord, Lord Rosenfield. I will confine my comments to the life sciences sector and in so doing draw noble Lords’ attention to my registered interests, in particular the fact that I am chairman of the Office for...

NHS: Hospital Waiting Times - Question (23 Ion 2024)

Lord Kakkar: My Lords, I draw the House’s attention to my registered interest. Is the Minister able to confirm whether there is a systematic approach to assessment of risk for poor clinical outcome for those patients on the waiting list? This would help in the earlier identification of those where the poorest outcome might be predicted and therefore drive intervention earlier in those cases.

National Health Service: Key Targets - Question (16 Ion 2024)

Lord Kakkar: My Lords, I draw attention to my registered interests. The long-term—and, indeed, the short and medium-term—sustainability of the NHS is critically dependent upon active engagement in research and the adoption of innovation at scale and pace. Is the Minister content that His Majesty’s Government are doing enough to ensure that the NHS is resourced to support that research and innovation...

Deaths: Younger Age Cohorts - Question (11 Ion 2024)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my registered interests. A substantial research effort that not only attended the Covid-19 pandemic but came subsequently to that has resulted, particularly in the field of the management of cardiovascular disease, in the identification of novel biomarkers and advanced imaging techniques that will allow for earlier and more accurate detection of...

King’s Speech - Debate (2nd Day) ( 8 Tach 2023)

Lord Kakkar: My Lords, it is a distinct pleasure and privilege to follow the noble and learned Lord—my noble and learned friend—Lord Burnett of Maldon, and to be the first in your Lordships’ House to congratulate him on his marvellous maiden speech. As he can see, it was deeply appreciated by all Members of the House. My noble and learned friend has had a most distinguished legal career. He was...

NHS Waiting Times: Long-Term Sickness Absence - Question (19 Hyd 2023)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my registered interests. While patients with chronic conditions wait for intervention, there is inevitable disease progression. Have His Majesty’s Government been able to make an assessment of the impact on the ultimate clinical outcome of these delays, as a result of disease progressing?

Climate Change - Motion to Take Note (24 Gor 2023)

Lord Kakkar: My Lords, I join other noble Lords in thanking my noble friend Lord Krebs for the very thoughtful way in which he introduced the debate. I declare my interests as chairman of the King’s Fund and chairman of King’s Health Partners. I will focus, over the next three minutes or so, on the question of adaptation to climate change and the potential impact on the delivery of healthcare in our...

Advanced Artificial Intelligence - Motion to Take Note (24 Gor 2023)

Lord Kakkar: My Lords, it is a distinct pleasure to follow the noble Lord, Lord Browne of Ladyton, and to join other noble Lords in congratulating my noble friend Lord Ravensdale on the very thoughtful way in which he introduced this important debate. I declare my interests as chairman of King’s Health Partners, chairman of the King’s Fund and chairman of the Office for Strategic Coordination of...

Stroke Care - Question (24 Gor 2023)

Lord Kakkar: My Lords, I draw noble Lords’ attention to my registered interests. It is clearly important that stroke networks are properly supported to deliver clinical care efficiently and effectively but, beyond the capacity to do that, there must also be ongoing capacity to participate in further research and development and to provide the opportunity for appropriate clinical evaluation of...

Medical Research Charities - Question (21 Meh 2023)

Lord Kakkar: My Lords, I draw the House’s attention to my registered interests. Is the Minister able to explain how the funding that had originally been allocated to the Horizon programme and has not been spent on that programme to date has been applied, and can he confirm that the residual funds that have not been applied will be applied to drive the science agenda in our country?

Metastatic and Secondary Breast Cancer - Question (19 Meh 2023)

Lord Kakkar: My Lords, I draw the House’s attention to my registered interests. It is one thing to collect data, but it is quite another to ensure that those data are appropriately curated and are available to drive improvements in clinical practice and provide the opportunity to accelerate the innovation agenda for the NHS through research and development. Is the Minister content that His Majesty’s...

Drugs: Supply and Availability - Question (14 Meh 2023)

Lord Kakkar: My Lords, I draw the attention of the House to my registered interests. What assessment have His Majesty’s Government made of the importance of securing an effective environment for clinical research, in ensuring that major developers of innovative therapies continue to provide those therapies to the citizens of our country?

Brain Tumours - Question (24 Ebr 2023)

Lord Kakkar: My Lords, I refer to my registered interests. Is the Minister content that there is sufficient investment in the basic infrastructure to deliver clinical research in the NHS to ensure that novel therapies to treat brain cancers can be evaluated in a timely and efficient fashion, especially within the context of the substantial challenges that the NHS is facing as it deals with clinical backlogs?

Stroke Rehabilitation and Community Services - Question (22 Maw 2023)

Lord Kakkar: My Lords, I draw attention to my declared interests. One of the most effective ways to reduce the burden of disease associated with stroke is to intervene earlier in trying to prevent stroke. What approach do His Majesty’s Government take to screening in the community and in populations for risk factors such as heart rhythm disorders, which, once identified, might be managed appropriately...


1 2 3 4 5 6 7 8 9 10 > >>

Creu hysbysiad

Chwilio uwch

Dod o hyd i'r union air neu ymadrodd hwn

Gallwch hefyd wneud hyn o'r prif flwch chwilio drwy roi’r union eiriau mewn dyfyniadau: megis "seiclo" neu "adroddiad Hutton"

Rydyn ni'n dangos geiriau sy'n gysylltiedig â'ch term chwilio, megis “beic” a “beicio” wrth chwilio am seiclo yn ddiofyn. Er mwyn atal hyn, rhowch y gair mewn dyfyniadau, fel "seiclo"

Heb gynnwys y geiriau hyn

Gallwch hefyd wneud hyn o'r prif flwch chwilio trwy roi arwydd minws cyn geiriau nad ydych eisiau: fel hela -llwynog

Rydym hefyd yn cefnogi nifer o addasiadau chwilio Booleaidd, megis AND a NEAR, ar gyfer chwilio manwl.

Ystod o ddyddiadau

i

Gallwch roi dyddiad dechrau, dyddiad gorffen, neu'r ddau er mwyn cyfyngu canlyniadau i ystod o ddyddiadau penodol. Mae dyddiad gorffen coll yn awgrymu'r dyddiad presennol, ac mae dyddiad cychwyn coll yn awgrymu'r dyddiad hynaf sydd gennym yn y system. Gellir nodi'r dyddiadau ar unrhyw fformat y dymunwch, e.e. 3ydd Mawrth 2007 neu 17/10/1989

Person

Rhowch enw fan hyn i gyfyngu canlyniadau i gyfraniadau gan y person hwnnw yn unig.

Adran

Cyfyngu canlyniadau i senedd neu gynulliad penodol yr ydym yn cynnwys (e.e. Senedd yr Alban), neu fath arbennig o ddata o fewn sefydliad, megis Atebion Ysgrifenedig Tŷ'r Cyffredin.

Colofn

Pe baech yn gwybod y rhif colofn Hansard cywir o'r wybodaeth y mae gennych ddiddordeb ynddo (efallai eich bod yn edrych ar gyfeiriad papur), gallwch gyfyngu canlyniadau i hynny ; Gallwch hefyd ddefnyddio column:123 yn y prif flwch chwilio.